Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 40,000 shares at $39.89 ($1.6M) on 2016-10-17, disclosed to the SEC on 2016-10-19.
Open-market purchase of $1.6M TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.89 | 4,300 | $172K | 10.7% |
| 2 | $40.10 | 27,400 | $1.1M | 68.6% |
| 3 | $40.04 | 8,300 | $332K | 20.7% |
| Total | $40.06 avg | 40,000 | $1.6M | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-11-02 | $628K | — | Filing → |